Application of single-cell sequencing technology and its clinical implications in Parkinson’s disease and Alzheimer’s disease: a narrative review
Применение технологии секвенирования отдельных клеток и её клиническое значение при болезни Паркинсона и болезни Альцгеймера: нарративный обзор
2025-02-06
SCID: 54.1/cpgfdtts
Discuss with AI
Alzheimer’s diseaseParkinson’s diseasesingle-cell sequencingsingle-nucleus sequencingspatial sequencing
Figures from the paper
Abstract (AI)
Genetic materials, including DNA and RNA molecules in the nucleus and cytosol, contain vital information related to protein production, metabolic regulation, and signal transduction. Understanding these molecules and their expression levels is important for research in different fields of biology, especially in the study of human disease. Owing to the development of next-generation sequencing technology, single-cell sequencing technology measures gene expression levels from mRNAs through the process of reverse transcription, allowing researchers to gain insights into the overexpression/low expression of specific proteins in various cells in particular disease models, which could help researchers explore the signaling pathways associated with the cellular and molecular mechanisms of these diseases. For example, single-cell sequencing has revealed the selective vulnerability of dopamine neurons and nuclear factor κB signaling pathway pathways associated with the progression of Parkinson’s disease. In Alzheimer’s disease research, single-cell sequencing has helped identify subpopulations of cells associated with disease pathology and has provided insights into the inflammatory response associated with the disease. Herein, we review the application of single-cell sequencing technology and its clinical implications in Parkinson’s disease and Alzheimer’s disease. As life expectancy increases annually, the incidence of neurodegenerative diseases is on the rise. This trend underscores the urgency and relevance of the use of single-cell sequencing to explore the anomalous expression levels of pathogenic genes and related signaling pathways in different brain regions. This paper introduces three subtypes of total RNA sequencing, namely, single-nucleus sequencing, single-cell sequencing, and spatial sequencing. It also introduces several advanced applications of these technologies in the research of Parkinson’s disease and Alzheimer’s disease. At the same time, this paper also explores the challenges contained in these sequencing methods and discusses their possible developments in the future. Overall, single-cell sequencing technology provides new tools and methods for Parkinson’s disease and Alzheimer’s disease research. Despite these challenges, there is great potential to improve our understanding of these complex diseases and to develop new therapies.
Key Findings
1
In Alzheimer’s disease, single-cell sequencing has identified disease-associated cellular subpopulations and provided insights into inflammatory responses.
2
In Parkinson’s disease, single-cell sequencing has revealed selective vulnerability of dopamine neurons and implicated nuclear factor κB signaling in disease progression.
3
Single-cell sequencing may support clinical research by characterizing pathogenic gene expression and signaling pathways across different brain regions.
4
Single-cell sequencing quantifies cell-specific gene expression, enabling investigation of abnormal protein expression and disease-related signaling pathways.
5
The review covers three RNA-sequencing approaches—single-nucleus, single-cell, and spatial sequencing—and their advanced applications in Parkinson’s and Alzheimer’s disease research.
Research Object
Parkinson’s disease and Alzheimer’s disease, including their brain cells and brain-region-specific molecular profiles
Research Subject
The application of single-cell, single-nucleus, and spatial RNA sequencing to characterize cell-type-specific gene-expression abnormalities, vulnerable cell populations, inflammatory and signaling pathways, and disease mechanisms and clinical implications
Publication Details
Publication Date
2025-02-06
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest